In Vitro Metabolism of the Novel, Highly Selective Oral Angiogenesis Inhibitor Motesanib Diphosphate in Preclinical Species and in Humans-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Vitro Metabolism of the Novel, Highly Selective Oral Angiogenesis Inhibitor Motesanib Diphosphate in Preclinical Species and in Humans

Published:2009-04-16 Issue:7 Volume:37 Page:1378-1394
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Li Chun,Kuchimanchi Mita,Hickman Dean,Poppe Leszek,Hayashi Mike,Zhou Yihong,Subramanian Raju,Kumar Gondi,Surapaneni Sekhar

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference30 articles.

1. Role of N-ghicuronidation in benzidine-induced bladder cancer in dog

2. Drug Metabolites in Safety Testing

3. METABOLISM AND PHARMACOKINETICS OF A DIPEPTIDYL PEPTIDASE IV INHIBITOR IN RATS, DOGS, AND MONKEYS WITH SELECTIVE CARBAMOYL GLUCURONIDATION OF THE PRIMARY AMINE IN DOGS

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of topical motesanib in experimental corneal neovascularization model;International Ophthalmology;2023-03-27

2. Towards New Sila- or Germa-Derivatives of Motesanib;HETEROCYCLES;2018

3. Population pharmacokinetic modeling of motesanib and its active metabolite, M4, in cancer patients;Clinical Pharmacology in Drug Development;2015-07-23

4. Platelet-Rich Plasma Promotes Axon Regeneration, Wound Healing, and Pain Reduction: Fact or Fiction;Molecular Neurobiology;2015-06-06

5. Efficacy of motesanib diphosphate in non-small-cell lung cancer;Expert Opinion on Pharmacotherapy;2014-07-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP